| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/06/2006 | US20060148059 Salt tolerant l-myo-inositol 1-phosphate synthase and the process of obtaining the same |
| 07/06/2006 | US20060148056 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 07/06/2006 | US20060148054 Enzymes for starch processing |
| 07/06/2006 | US20060148053 Process for the biological production of 1,3-propanediol with high titer |
| 07/06/2006 | US20060148052 Production of polyketides in bacteria and yeast |
| 07/06/2006 | US20060148050 Yeast strains for the production of lactic acid |
| 07/06/2006 | US20060148049 Gene disrupted yeast |
| 07/06/2006 | US20060148048 Process for acyl-transfer enzyme reactions with acyl-coenzyme a |
| 07/06/2006 | US20060148042 Biotransformation to produce stereospecific drug; reacting a substituted arylaldehydes and 2-oxoacids using 2-hydroxy-3-oxoacid synthases; bacterial origin, yeast enzyme, Escherichia coli, fungal enzyme, and plant; pure enantiomers (R)-phenylacetyl carbinol |
| 07/06/2006 | US20060148041 Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 07/06/2006 | US20060148039 Methylotroph producing mammalian type sugar chain |
| 07/06/2006 | US20060148038 Thrombin cleavable factor x analogues |
| 07/06/2006 | US20060148035 Host cells containing mannosidase catalytic domains within endoplasmic reticulum or Golgi complex for producing glycoproteins with glycan structures attached in glycoform that serve as substrate for transferases |
| 07/06/2006 | US20060148033 A vector having a portion encoding a 5'-untranslated region from an mRNA for a cold shock protein gene that has a mutation that changes the distance of the stem structure formed by the region; used for genetic engineering |
| 07/06/2006 | US20060148031 Hemipteran myosin light chain kinase |
| 07/06/2006 | US20060148026 Engineering redox proteins |
| 07/06/2006 | US20060148020 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060148017 Compositions and methods for monitoring enzyme activity |
| 07/06/2006 | US20060148013 use of RL9/RL10 protein and the polynucleotides encoding RL9/RL10 protein, e.g., in diagnosing and treating tumor, as well as the pharmaceutical composition containing RL9/RL10 protein or the antibody against it |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060148007 Using cells which over express g-protein coupled receptors as drug screening tools; high throughput and signal transduction assays |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060148001 Compositions and methods for treating female fertility |
| 07/06/2006 | US20060147995 Method for producing antibody fragments |
| 07/06/2006 | US20060147990 Using polymerase chain reaction to amplify preferential DNA sequences for use directed translation events |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147986 Gene and protein libraries and methods relating thereto |
| 07/06/2006 | US20060147982 32 human secreted proteins |
| 07/06/2006 | US20060147980 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 07/06/2006 | US20060147979 Methods for forming recombined nucleic acids |
| 07/06/2006 | US20060147978 Methods and compositions for screening for altered cellular phenotypes |
| 07/06/2006 | US20060147976 Method of detecting and quantitating microorganism having specific function and its gene from natural environment using novel 16SrRNA gene data or probes |
| 07/06/2006 | US20060147975 Method for assaying protein-protein interaction |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147967 high processivity and strand-displacement activity |
| 07/06/2006 | US20060147956 Contacting nucleic acid with probe which binds to polynucleotide sequence on genomic region in which copy number is increased; labeled with digoxigenin or biotin |
| 07/06/2006 | US20060147952 2'-O-methyl-phosphorothioate oligoribonucleotide modification; peptide nucleic acids, locked nucleic acids, and/or morpholino phosphorodiamidate oligonucleotides; splicing to skip hybridization |
| 07/06/2006 | US20060147951 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 07/06/2006 | US20060147950 Precursor conversion screening method |
| 07/06/2006 | US20060147937 Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences |
| 07/06/2006 | US20060147923 Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3 |
| 07/06/2006 | US20060147921 Method of amplifying nucleic acid and apparatus therefor |
| 07/06/2006 | US20060147920 Method of judging inflammatory disease |
| 07/06/2006 | US20060147918 Stabilisation of nucleic acids |
| 07/06/2006 | US20060147917 Information processing system using base sequence relevant information |
| 07/06/2006 | US20060147916 Probe carrier and method of producing same |
| 07/06/2006 | US20060147913 Method of analyzing substance on substrate by mass spectrometry |
| 07/06/2006 | US20060147910 Detection of mutations |
| 07/06/2006 | US20060147909 Microstructures and use thereof for the directed evolution of biomolecules |
| 07/06/2006 | US20060147908 "Prionins", highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans. |
| 07/06/2006 | US20060147902 Yeast screens for treatment of human disease |
| 07/06/2006 | US20060147581 Hybrid enzymes |
| 07/06/2006 | US20060147514 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/06/2006 | US20060147513 Methods of forming targeted liposomes loaded with a therapeutic agent |
| 07/06/2006 | US20060147499 Proteases |
| 07/06/2006 | US20060147477 Immunogenic compositions |
| 07/06/2006 | US20060147474 Detection of antibodies against chamydia trachomatis PGP3 antigen in patient sera by enzyme-linked immunoassay |
| 07/06/2006 | US20060147469 Recombinant hepatitis a virus antigens obtained in plant cells |
| 07/06/2006 | US20060147462 For diagnostic, prophylactic and therapeutic uses, vaccines against bacterial infections |
| 07/06/2006 | US20060147461 Use of ClyA hemolysin for excretion of proteins |
| 07/06/2006 | US20060147458 Vaccines |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147452 Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060147444 Biosynthetic binding proteins for immuno-targeting |
| 07/06/2006 | US20060147438 Bacterial bioherbicide for control of grassy weeds |
| 07/06/2006 | US20060147436 interferon type 1 receptor 1 (IFNAR1)-binding proteins, used to enhanced the exogenous therapy or treatment of cancer |
| 07/06/2006 | US20060147435 Using glycogen synthase kinase-3 (GSK-3) inhibitors to increase endogenous hematopoietic adult stem cell or progenitor cell population in mammals for treatment of immune related, mesenchymal/mesoderm degenerative and/or neurodegenerative diseases |
| 07/06/2006 | US20060147421 Methods and compositions for treating and preventing infection using human interferon regulatory factor 3 |
| 07/06/2006 | US20060147420 Oncolytic adenovirus armed with therapeutic genes |
| 07/06/2006 | US20060147419 Recombinant vaccine viruses expressing il-15 and methods of using the same |
| 07/06/2006 | US20060147418 Recombinant double stranded rna phages and uses thereof |
| 07/06/2006 | US20060147377 tumor cell line, reponsive to histone deacetylase inhibitors, transfected with vector containing reporter gene such as fluorescent protein, linked to promotor that also controls expression of protein associated with tumor regression, stabilization of tumor growth or inhibition of metastatic growth |
| 07/06/2006 | US20060147373 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | US20060147372 DNA encoding MCK-10, a novel receptor tyrosine kinase |
| 07/06/2006 | DE112004001603T5 TGF-β-Genexpressionsinhibitor TGF-β gene expression inhibitor |
| 07/06/2006 | DE10225380B4 Produktion und Sekretion von Glucosyltransferasen Production and secretion of glucosyltransferases |
| 07/06/2006 | DE102005031910A1 Verfahren zum Stabilisieren oder Isolieren von Nucleinsäuren A method for stabilizing or isolating nucleic acids |
| 07/06/2006 | DE102004063326A1 Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenen Organismen A process for the production of polyunsaturated fatty acids in transgenic organisms |
| 07/06/2006 | DE102004063150A1 Permeabilization of biological membranes (especially of living cells) to allow passage of nanoscalar foreign bodies (especially DNA) involves producing a field in a solution containing the optionally supported bodies |
| 07/06/2006 | DE102004062543A1 Preparing unsaturated fatty acid derivatives, for use e.g. as pharmaceuticals and cosmetics, in seeds of transgenic plants, comprises growing plants that contain specific elongase and desaturase genes |
| 07/06/2006 | DE102004062294A1 Verfahren zur Herstellung von mehrfach ungesättigten langkettigen Fettsäuren in transgenen Organismen Process for the preparation of polyunsaturated long chain fatty acids in transgenic organisms |
| 07/06/2006 | DE102004061903A1 New isolated polynucleotide based on gene isolated from Heliothis virescens, encoding insect neurokinin receptor, useful as target in screening for receptor modulating pesticides |
| 07/06/2006 | DE102004061902A1 New isolated insect polynucleotide based on gene isolated from Heliothis virescens, encoding insect sphingosine-1-phosphate lyase, useful as target in screening for enzyme inhibiting pesticides |
| 07/06/2006 | DE102004061696A1 Mutante des proB-Gens aus coryneformen Bakterien Mutant of the proB gene from coryneform bacteria |
| 07/06/2006 | DE102004061052A1 Verfahren zum Nachweis von Herzerkrankungen A method for the detection of heart disease |
| 07/06/2006 | DE10045687B4 Expressionskassetten und Adenovirusvektoren Expression cassettes and adenovirus vectors |
| 07/06/2006 | DE10014638B4 cDNA's, kodierend für Proteine mit Chitinaseaktivität, für eine Niedertemperatur-Expression sowie Verfahren zu deren Isolierung cDNAs encoding proteins with chitinase activity, for a low-temperature expression as well as methods for their isolation |
| 07/06/2006 | CA2623874A1 Wnt4 in supporting lymphopoiesis |
| 07/06/2006 | CA2610360A1 E1-minus adenoviruses and use thereof |
| 07/06/2006 | CA2594245A1 Retrotransposon inhibition in therapy |
| 07/06/2006 | CA2594155A1 A process for producing a food or beverage |
| 07/06/2006 | CA2592894A1 Improved grain quality through altered expression of gamma-zein protein |
| 07/06/2006 | CA2592699A1 Method for reversing multiple resistance in animal cells |
| 07/06/2006 | CA2592648A1 Methods and compositions for treating epithelial cancers |
| 07/06/2006 | CA2592461A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | CA2592425A1 Ligation-based rna amplification |
| 07/06/2006 | CA2592100A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 07/06/2006 | CA2591599A1 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |